Cognition Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2024 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q3 2024 | 2 | -$0.30 | -$0.12 | -$0.21 |
| Q1 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Cognition Therapeutics, Inc. Earnings Date And Information
Cognition Therapeutics, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.18 earnings per share for the quarter, topping analysts' consensus estimates of $-0.22 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cognition Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.86 diluted earnings per share) and currently has a price-to-earnings ratio of -0.5. Cognition Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Cognition Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.25 | $0 | $0 | ||
| 08/08/2024 | Q2 2024 | -$0.22 | -$0.18 | 0.04 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.23 | -$0.27 | -0.04 | $0 | |
| 03/26/2024 | Q4 2023 | -$0.38 | -$0.26 | 0.12 | $372,000 | |
| 11/02/2023 | Q3 2023 | -$0.31 | -$0.22 | 0.09 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.25 | -$0.16 | 0.09 | $0 | |
| 05/04/2023 | Q1 2023 | -$0.17 | -$0.12 | 0.05 | $0 | |
| 03/23/2023 | Q4 2022 | -$0.49 | $0.38 | 0.87 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.55 | -$0.03 | 0.52 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.31 | -$0.25 | 0.06 | $0 | |
| 05/11/2022 | Q1 2022 | -$0.27 | -$0.17 | 0.1 | $0 | |
| 03/30/2022 | Q4 2021 | -$0.35 | $0 | |||
| 11/17/2021 | Q3 2021 | -$0.57 | -$0.15 | 0.42 | $0 | |
| 06/29/2021 | Q2 2021 | -$0.07 | $0 | |||
| 03/30/2021 | Q1 2021 | $0.01 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.09 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.08 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.08 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.12 | $0 |
Cognition Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Cognition Therapeutics, Inc.'s earnings date?
Cognition Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
Did Cognition Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Cognition Therapeutics, Inc. (:CGTX) reported $-0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.22 by $0.04.
-
How can I listen to Cognition Therapeutics, Inc.'s earnings conference call?
The conference call for Cognition Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Cognition Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Cognition Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Cognition Therapeutics, Inc. generate each year?
Cognition Therapeutics, Inc. (:CGTX) has a recorded net income of $0. Cognition Therapeutics, Inc. has generated $-0.86 earnings per share over the last four quarters.
-
What is Cognition Therapeutics, Inc.'s price-to-earnings ratio?
Cognition Therapeutics, Inc. (:CGTX) has a price-to-earnings ratio of -0.5 and price/earnings-to-growth ratio is 0.16.
